LSK Global PS Expanding Use of Medidata Platform

Article

LSK Global PS announces that it will expand its use of Medidata’s Clinical Trial Management Solution.

LSK Global PS announces that it will expand its use of Medidata’s Clinical Trial Management Solution. The Korean CRO aims to improve oversight into trial operations and streamline its site monitoring processes using this tool.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.